(3R,5S,8S)-8-[(2R)-butan-2-yl]-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-7-oxo-2-oxa-11-thia-6,9,24,27-tetrazapentacyclo[16.6.2.13,6.110,13.021,25]octacosa-1(24),10(27),12,16,18(26),19,21(25),22-octaene-5-carboxamide
C36H42N6O6S2 — CID 137099354
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3R,5S,8S)-8-[(2R)-butan-2-yl]-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-7-oxo-2-oxa-11-thia-6,9,24,27-tetrazapentacyclo[16.6.2.13,6.110,13.021,25]octacosa-1(24),10(27),12,16,18(26),19,21(25),22-octaene-5-carboxamide
(3R,5S,8S)-8-[(2R)-butan-2-yl]-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-7-oxo-2-oxa-11-thia-6,9,24,27-tetrazapentacyclo[16.6.2.13,6.110,13.021,25]octacosa-1(24),10(27),12,16,18(26),19,21(25),22-octaene-5-carboxamide (PubChem CID 137099354) has the molecular formula C36H42N6O6S2 and a molecular weight of 718.90 g/mol. Its IUPAC name is (3R,5S,8S)-8-[(2R)-butan-2-yl]-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-7-oxo-2-oxa-11-thia-6,9,24,27-tetrazapentacyclo[16.6.2.13,6.110,13.021,25]octacosa-1(24),10(27),12,16,18(26),19,21(25),22-octaene-5-carboxamide.
Molecular Properties
| Compound Name | (3R,5S,8S)-8-[(2R)-butan-2-yl]-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-7-oxo-2-oxa-11-thia-6,9,24,27-tetrazapentacyclo[16.6.2.13,6.110,13.021,25]octacosa-1(24),10(27),12,16,18(26),19,21(25),22-octaene-5-carboxamide |
|---|---|
| PubChem CID | 137099354 |
| Molecular Formula | C36H42N6O6S2 |
| Molecular Weight | 718.90 g/mol |
| Exact Mass | 718.26 |
| IUPAC Name | (3R,5S,8S)-8-[(2R)-butan-2-yl]-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-7-oxo-2-oxa-11-thia-6,9,24,27-tetrazapentacyclo[16.6.2.13,6.110,13.021,25]octacosa-1(24),10(27),12,16,18(26),19,21(25),22-octaene-5-carboxamide |
| SMILES | C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H]([C@H](C)CC)Nc1nc(cs1)CCC=Cc1ccc3ccnc(c3c1)O2)C(=O)NS(=O)(=O)C1CC1 |
| InChI | InChI=1S/C36H42N6O6S2/c1-4-21(3)30-33(44)42-19-26(17-29(42)31(43)40-36(18-24(36)5-2)34(45)41-50(46,47)27-12-13-27)48-32-28-16-22(10-11-23(28)14-15-37-32)8-6-7-9-25-20-49-35(38-25)39-30/h5-6,8,10-11,14-16,20-21,24,26-27,29-30H,2,4,7,9,12-13,17-19H2,1,3H3,(H,38,39)(H,40,43)(H,41,45)/t21-,24-,26-,29+,30+,36-/m1/s1 |
| InChIKey | OSBRJPGQZUHKDR-TWSFAMDJSA-N |
| XLogP | 4.20 |
| TPSA | 159.69 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 50 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 718.90 |
| LogP ≤ 5 | 4.20 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 137099354 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.